Development and Phantom Validation of a 3-D-Ultrasound-Guided System for Targeting MRI-Visible Lesions During Transrectal Prostate Biopsy
Authors:
- Yipeng HuYHYipeng Hu
- Veeru KasivisvanathanVKVeeru Kasivisvanathan
- Lucy A. M. SimmonsLSLucy A. M. Simmons
- Matthew J. ClarksonMCMatthew J. Clarkson
- Stephen A. ThompsonSTStephen A. Thompson
- Taimur T. ShahTSTaimur T. Shah
- Hashim U. AhmedHAHashim U. Ahmed
- Shonit PunwaniSPShonit Punwani
- David J. HawkesDHDavid J. Hawkes
- Mark EmbertonMEMark Emberton
- Caroline M. MooreCMCaroline M. Moore
- Dean C. BarrattDBDean C. Barratt
Open Access
- 21 June 2016
- journal article
- research article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 64 (4) , 946-958
Abstract
Objective: Three- and four-dimensional transrectal ultrasound transducers are now available from most major ultrasound equipment manufacturers, but currently are incorporated into only one commercial prostate biopsy guidance system. Such transducers offer the benefits of rapid volumetric imaging, but can cause substantial measurement distortion in electromagnetic tracking sensors, which are commonly used to enable 3-D navigation. In this paper, we describe the design, development, and validation of a 3-D-ultrasound-guided transrectal prostate biopsy system that employs high-accuracy optical tracking to localize the ultrasound probe and prostate targets in 3-D physical space. Methods: The accuracy of the system was validated by evaluating the targeted needle placement error after inserting a biopsy needle to sample planned targets in a phantom using standard 2-D ultrasound guidance versus real-time 3-D guidance provided by the new system. Results: The overall mean needle-segment-to-target distance error was 3.6 ± 4.0 mm and mean needle-to-target distance was 3.2 ± 2.4 mm. Conclusion: A significant increase in needle placement accuracy was observed when using the 3-D guidance system compared with visual targeting of invisible (virtual) lesions using a standard B-mode ultrasound-guided biopsy technique.Keywords
Funding Information
- Prostate Cancer UK research project (PG10-30)
- Health Innovation Challenge (HIC) Fund (HICF-T4-310)
- Doctoral Research Fellowship (DRF-2014-07-146)
- National Institute for Health Research
- HIC Fund, a parallel funding partnership between the Department of Health and the Wellcome Trust
This publication has 43 references indexed in Scilit:
- MRI–ultrasound fusion for guidance of targeted prostate biopsyCurrent Opinion in Urology, 2013
- Targeted Biopsy in the Detection of Prostate Cancer Using an Office Based Magnetic Resonance Ultrasound Fusion DeviceJournal of Urology, 2013
- Robotic Transperineal Prostate Biopsy: Pilot Clinical StudyUrology, 2011
- Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy Improves Cancer Detection Following Transrectal Ultrasound Biopsy and Correlates With Multiparametric Magnetic Resonance ImagingJournal of Urology, 2011
- Mechanically assisted 3D ultrasound guided prostate biopsy systemMedical Physics, 2008
- Design and evaluation of a 3D transrectal ultrasound prostate biopsy systemMedical Physics, 2008
- Effect of 3D ultrasound probes on the accuracy of electromagnetic tracking systemsUltrasound in Medicine & Biology, 2006
- The Changing Face of Low-Risk Prostate Cancer: Trends in Clinical Presentation and Primary ManagementJournal of Clinical Oncology, 2004
- Three-dimensional ultrasound imagingPhysics in Medicine & Biology, 2001
- Comparative tracking error analysis of five different optical tracking systemsComputer Aided Surgery, 2000